Jan Madsen Sells 2,439 Shares of Maximus, Inc. (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMS) Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Maximus Stock Up 0.3 %

Shares of MMS traded up $0.19 during mid-day trading on Wednesday, reaching $68.74. The company’s stock had a trading volume of 432,431 shares, compared to its average volume of 481,637. The company’s 50 day moving average is $71.48 and its 200 day moving average is $78.89. The stock has a market cap of $3.89 billion, a PE ratio of 14.78 and a beta of 0.71. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently bought and sold shares of MMS. UMB Bank n.a. raised its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank acquired a new position in shares of Maximus during the 4th quarter worth approximately $29,000. V Square Quantitative Management LLC boosted its position in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd bought a new position in shares of Maximus during the fourth quarter valued at $54,000. Finally, IFP Advisors Inc increased its stake in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.